Newron Pharmaceuticals (NWPHF) Short Interest Ratio & Short Volume → POTUS in ‘25 Not Biden/Trump, But (From The Freeport Society) (Ad) Free NWPHF Stock Alerts $12.00 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Newron Pharmaceuticals Short Interest DataCurrent Short Volume28,200 sharesPrevious Short Volume100 sharesChange Vs. Previous Month+28,100.00%Dollar Volume Sold Short$240,264.00Short Interest Ratio / Days to Cover282.0Last Record DateApril 30, 2024Outstanding Shares17,850,000 sharesPercentage of Shares Shorted0.16%Today's Trading Volume0 sharesAverage Trading Volume1,525 sharesToday's Volume Vs. Average0% Short Selling Newron Pharmaceuticals ? Sign up to receive the latest short interest report for Newron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNWPHF Short Interest Over TimeNWPHF Days to Cover Over TimeNWPHF Percentage of Float Shorted Over Time Ad Crypto 101 MediaThe Overlooked Retirement Asset You Probably Don’t Own4 out of 5 Americans believe we’re on the brink of a retirement crisis. Luckily, in these unprecedented times, we have an unprecedented solution. Once considered a “fringe” investment, the crypto market is now taking the world by storm.Click here to access the Crypto Retirement Blueprint now. Newron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/202428,200 shares $240,264.00 +28,100.0%N/A282 $8.52 4/15/2024100 shares $852.00 -99.8%N/A0 $8.52 3/31/202444,600 shares $379,992.00 +50.7%N/A0 $8.52 3/15/202429,600 shares $252,192.00 +60.0%N/A0 $8.52 2/29/202418,500 shares $157,620.00 +537.9%N/A0 $8.52 2/15/20242,900 shares $24,708.00 +480.0%N/A0 $8.52 Get the Latest News and Ratings for NWPHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Newron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/20242,700 shares $21,330.00 -89.2%N/A6.8 $7.90 12/31/202324,900 shares $129,978.00 +66.0%N/A101.9 $5.22 12/15/202315,000 shares $93,300.00 -35.3%N/A0 $6.22 11/30/202323,200 shares $144,304.00 -27.0%N/A0 $6.22 11/15/202331,800 shares $197,796.00 +27.2%N/A0 $6.22 10/31/202325,000 shares $155,500.00 +24,900.0%N/A0 $6.22 10/15/2023100 shares $622.00 -99.5%N/A0 $6.22 9/30/202318,600 shares $115,692.00 -22.5%N/A0 $6.22 9/15/202324,000 shares $149,280.00 +566.7%N/A0 $6.22 8/31/20233,600 shares $22,392.00 -63.3%N/A35 $6.22 8/15/20239,800 shares $19,796.00 -10.9%N/A0 $2.02 7/31/202311,000 shares $22,220.00 +10,900.0%N/A0 $2.02 7/15/2023100 shares $202.00 No ChangeN/A1 $2.02 6/30/2023100 shares $202.00 No ChangeN/A0 $2.02 6/15/2023100 shares $202.00 No ChangeN/A0 $2.02 5/31/2023100 shares $202.00 -97.1%N/A0 $2.02 5/15/20233,500 shares $7,070.00 +3,400.0%N/A0 $2.02 4/30/2023100 shares $202.00 -99.5%N/A0 $2.02 4/15/202319,200 shares $38,784.00 -70.4%N/A0 $2.02 3/31/202364,900 shares $131,098.00 -35.5%N/A0 $2.02 3/15/2023100,600 shares $203,212.00 +21.5%N/A0 $2.02 2/28/202382,800 shares $167,256.00 +82,700.0%N/A828 $2.02 2/15/2023100 shares $202.00 -91.7%N/A0 $2.02 1/31/20231,200 shares $2,424.00 +1,100.0%N/A0 $2.02 1/15/2023100 shares $202.00 No ChangeN/A1 $2.02 12/15/2022100 shares $210.00 No ChangeN/A0 $2.10 11/30/2022100 shares $210.00 No ChangeN/A0 $2.10 11/15/2022100 shares $210.00 No ChangeN/A0 $2.10 10/31/2022100 shares $210.00 No ChangeN/A0 $2.10 10/15/2022100 shares $210.00 No ChangeN/A0 $2.10 9/30/2022100 shares $210.00 No ChangeN/A0 $2.10 9/15/2022100 shares $210.00 No ChangeN/A0 $2.10 8/31/2022100 shares $210.00 No ChangeN/A0 $2.10 8/15/2022100 shares $210.00 No ChangeN/A0 $2.10get a piece of the profit from this land (Ad)This isn’t the prettiest land on earth. But it might be the most valuable. And you don’t have to own, lease, or rent any land.Click here to see my #1 investment for 2024. NWPHF Short Interest - Frequently Asked Questions What is Newron Pharmaceuticals' current short interest? Short interest is the volume of Newron Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 28,200 shares of NWPHF short. Learn More on Newron Pharmaceuticals' current short interest. What is a good short interest ratio for Newron Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NWPHF shares currently have a short interest ratio of 282.0. Learn More on Newron Pharmaceuticals's short interest ratio. Is Newron Pharmaceuticals' short interest increasing or decreasing? Newron Pharmaceuticals saw a increase in short interest in April. As of April 30th, there was short interest totaling 28,200 shares, an increase of 28,100.0% from the previous total of 100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Newron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Newron Pharmaceuticals: Incannex Healthcare Inc. (0.48%), CervoMed Inc. (1.06%), Cybin Inc. (3.51%), Prelude Therapeutics Incorporated (2.43%), I-Mab (1.43%), Skye Bioscience, Inc. (0.13%), InterCure Ltd. (0.15%), CytoDyn Inc. (0.47%), Regulus Therapeutics Inc. (7.33%), Elite Pharmaceuticals, Inc. (0.15%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Newron Pharmaceuticals stock? Short selling NWPHF is an investing strategy that aims to generate trading profit from Newron Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Newron Pharmaceuticals? A short squeeze for Newron Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NWPHF, which in turn drives the price of the stock up even further. How often is Newron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWPHF, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Incannex Healthcare Short Squeeze CervoMed Short Squeeze Cybin Short Squeeze Prelude Therapeutics Short Squeeze I-Mab Short Squeeze Skye Bioscience Short Squeeze InterCure Short Squeeze CytoDyn Short Squeeze Regulus Therapeutics Short Squeeze Elite Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWPHF) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsDems have chosen Biden replacement?Paradigm PressThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss RatingsBuy this small stock before coming AI Tidal WaveChaikin AnalyticsUrgent Nvidia WarningAltimetry